- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-2-2-mer
 - Ligands
 - 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
 NAG.22: 2 residues within 4Å:- Chain A: Y.28, N.61
 
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: N.122, T.124, V.127
 
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: E.132, N.165
 
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: G.232, N.234
 
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: N.280, E.281, N.282
 
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: N.603, T.604
 
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.616
 
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain A: N.657
 
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain A: N.709, I.1130, G.1131
 - Chain B: D.796
 
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: Y.28, N.61
 
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain B: N.122, T.124, V.127, K.129
 
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: N.164, N.165
 
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.234
 
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
 
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: F.338, G.339, N.343
 
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.603
 
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.616
 
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain B: N.657
 
Ligand excluded by PLIPNAG.40: 5 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
 - Ligands: NAG.41
 
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Ligands: NAG.40
 
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: Y.28, N.61
 
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain C: N.122, N.125, V.127, F.157
 
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.165
 
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.234
 
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: E.281, N.282
 
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.603
 
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.616
 
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: H.655, N.657
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Yan, R. et al., Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell Res. (2021)
          


 - Release Date
 - 2021-03-10
 - Peptides
 - Spike glycoprotein: ABC
IG c642_heavy_IGHV3-53_IGHD1-26_IGHJ6,Chain H of P2B-1A10,Immunoglobulin gamma-1 heavy chain: DF
Immunoglobulin kappa variable 1-33,Uncharacterized protein: EG - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
JE
KG
N 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-2-2-mer
 - Ligands
 - 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Yan, R. et al., Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell Res. (2021)
          


 - Release Date
 - 2021-03-10
 - Peptides
 - Spike glycoprotein: ABC
IG c642_heavy_IGHV3-53_IGHD1-26_IGHJ6,Chain H of P2B-1A10,Immunoglobulin gamma-1 heavy chain: DF
Immunoglobulin kappa variable 1-33,Uncharacterized protein: EG - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
JE
KG
N